Current pharmaceutical design | 2021

Recent Progresses of Deep Learning in Drug Discovery.

 
 
 
 

Abstract


Deep learning, an emerging field of artificial intelligence based on neural network in machine learning, has been applied in various fields and is highly valued. Herein we mainly review several mainstream architectures in deep learning, including deep neural networks, convolutional neural networks and recurrent neural networks in the field of drug discovery. The applications of several architectures in molecular de novo design, property prediction, biomedical imaging and synthetic planning have also been explored. We also discuss the future direction of the deep learning approaches and the main challenges we need to address.

Volume None
Pages None
DOI 10.2174/1381612827666210129123231
Language English
Journal Current pharmaceutical design

Full Text